GPT Healthcare
MAINBOARD
Listed
Price Band
₹177 - ₹186
Lot Size
80 Shares
Issue Size
₹40.00 Cr
Fresh Issue
₹28.00 Cr
OFS
₹12.00 Cr
Registrar
Link Intime India Private Limited
AI Sentiment Score
Listing Price
₹215.00
vs Issue: ₹186 (+15.59%)
📅 IPO Timeline
✓
Open
Feb 22, 2024
✓
Close
Feb 26, 2024
✓
Allotment
Feb 27, 2024
✓
Refund
Feb 28, 2024
✓
Demat
Feb 28, 2024
✓
Listing
Feb 29, 2024
📈 Grey Market Premium (GMP) Trendline
Daily consensus GMP movement (₹) recorded across market sources
✨ AI Analysis & Prediction
🔒 Final Reconciled Estimate
Locked post-listing with actual debut performance
GPT Healthcare displays an established operational footprint with expanding revenue streams (26.1% CAGR) and a defensible value proposition.
💪 Strengths
- Demonstrated operational revenue trajectory with resilient top-line growth (26.1% CAGR).
- Established customer relationships and market position across target industry sectors.
- Sound operational capital returns with Return on Capital Employed (ROCE) at 23.7%.
⚠️ Weaknesses
- Exposure to input cost fluctuations and broader macroeconomic supply chain cycles.
- Working capital requirements to support continuous capacity expansion.
- Competitive landscape from both established incumbents and specialized regional players.
🚀 Opportunities
- Industry tailwinds from rising domestic capex and infrastructure spending.
- Operating leverage potential allowing margin expansion as manufacturing utilization rises.
- Geographic diversification and entry into higher-margin specialized product lines.
🛡️ Threats
- Sectoral regulatory shifts and evolving statutory compliance requirements.
- Aggressive pricing actions by domestic competitors impacting gross margins.
- Broader market equity volatility and liquidity fluctuations.
📊 Financial Overview & Growth Trajectory
Multi-year operational scale & net profitability trajectory
| Metric | FY20 | FY21 | FY22 |
|---|---|---|---|
| Revenue (₹ Cr) | Rs 212.00 Cr | Rs 243.00 Cr | Rs 337.00 Cr |
| Net Profit / PAT (₹ Cr) | Rs 11.00 Cr | Rs 21.00 Cr | Rs 42.00 Cr |
| EBITDA / Op. Profit (₹ Cr) | Rs 36.00 Cr | Rs 49.00 Cr | Rs 74.00 Cr |
| Borrowings (₹ Cr) | Rs 157.00 Cr | Rs 163.00 Cr | Rs 96.00 Cr |
| Total Assets (₹ Cr) | Rs 308.00 Cr | Rs 317.00 Cr | Rs 323.00 Cr |
| ROE % | 0.00% | 0.00% | 0.00% |
| ROCE % | 23.70% | 23.70% | 23.70% |
| Debt / Equity | 0.00 | 0.00 | 0.00 |
Company P/E
29.1x
Industry P/E
33.5x
Debt/Equity
0.61
⚖️ Valuation Benchmark Range
🟢 Attractively Priced vs Industry Peers
Industry 33.5x
IPO 29.1x
0x (Deep Value)
45x (High Multiple)
📋 Live Subscription Status
QIB
17.30x
NII
11.98x
Retail
2.44x
Total
8.52x
🎯 Retail Allotment Probability
41% Odds
1 in 2.4 chance (~41% probability per PAN)
SEBI Rule: Under SEBI lottery allotment rules, applying for multiple lots under Retail does NOT increase your lottery odds. All valid retail applicants have identical 1-lot odds per PAN.
Updated: Sep 12, 2026 2:45 PM
💼 Issue Structure & Reservation Quota
Capital Structure
₹40.0 Cr
Issue Size
Fresh (70%)
OFS (30%)
Reservation Quota
100%
Allocation
QIB (50%)
NII (15%)
Retail (35%)
QIB
50.00%
Retail
35.00%
NII
15.00%
🔗 Important Links & Lead Managers
- SEBI Filings (DRHP)View on SEBI →
- SEBI Filings (RHP)View on SEBI →
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.